Cargando…
Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukemia definition
The presence of circulating plasma cells in patients with multiple myeloma is considered a marker for highly proliferative disease. In the study herein, the impact of circulating plasma cells assessed by cytology on survival of patients with multiple myeloma was analyzed. Wright-Giemsa stained perip...
Autores principales: | Granell, Miquel, Calvo, Xavier, Garcia-Guiñón, Antoni, Escoda, Lourdes, Abella, Eugènia, Martínez, Clara Mª, Teixidó, Montserrat, Gimenez, Mª Teresa, Senín, Alicia, Sanz, Patricia, Campoy, Desirée, Vicent, Ana, Arenillas, Leonor, Rosiñol, Laura, Sierra, Jorge, Bladé, Joan, de Larrea, Carlos Fernández |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451342/ https://www.ncbi.nlm.nih.gov/pubmed/28255016 http://dx.doi.org/10.3324/haematol.2016.158303 |
Ejemplares similares
-
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage
por: Fernández de Larrea, Carlos, et al.
Publicado: (2021) -
Treatment of Patients with Monoclonal Gammopathy of Clinical Significance
por: Moreno, David F., et al.
Publicado: (2021) -
Paraskeletal and extramedullary plasmacytomas in multiple myeloma at diagnosis and at first relapse: 50-years of experience from an academic institution
por: Jiménez-Segura, Raquel, et al.
Publicado: (2022) -
Plasma Cell Leukemia: Definition, Presentation, and Treatment
por: Gundesen, Michael Tveden, et al.
Publicado: (2019) -
P937: CARFILZOMIB, LENALIDOMIDE PLUS DEXAMETHASONE (KRD) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: UPDATE ANALYSIS OF REAL-LIFE EXPERIENCE OF GEMMAC GROUP.
por: Garcia-Guiñon, Antonio, et al.
Publicado: (2023)